National Cancer Institute
National Cancer Institute U.S. National Institutes of Health

Brain Malignancies Steering Committee

The Brain Malignancies Steering Committee (BMSC) was established in November of 2010. BMSC members include Cooperative Groups brain tumor disease committee chairs, representatives from Brain Tumor Consortia, translational scientists including brain Specialized Programs of Research Excellence (SPOREs), and R01/P01 investigators along with community oncologists, biostatisticians, patient advocates, and NCI staff.

Mission Statement

The BMSC functions to harmonize an efficient, cost-effective, science-driven, and transparent process that will identify and promote the "Best Science" in brain cancer clinical research by addressing the design, prioritization and evaluation of phase II, and all phase III clinical trials. The BMSC focus is in both adult and pediatric brain cancers.

Roster of Brain Malignancies Steering Committee (BMSC) members
Ian Pollack, M.D and W.K. Alfred Yung, M.D., Co-chairs

Clinical Trial Planning Meetings (CTPMs): Goal of Clinical Trial Planning Meetings, and List of CTPM Executive Summaries and Publications

CCCT Contact: Abdul Tawab Amiri, Ph.D.